Q&A: The IND Journey Phase I – Navigating Success
Advarra
JULY 19, 2022
Q: What is the typical time period between the submission of the briefing package and the pre-IND meeting? A: The FDA’s guidance document indicates the briefing package is submitted four weeks before the meeting. The sponsor-initiated IND is conducted by a pharma company seeking commercial approval.
52 
Let's personalize your content